Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome

S Gates, G D Perkins, S E Lamb, C Kelly, D R Thickett, J D Young, D F McAuley, C Snaith, C McCabe, C T Hulme, F Gao Smith

Inflammation and Ageing
Metabolism and Systems Research

Research output: Contribution to journal › Article › peer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome

Fingerprint

Medicine & Life Sciences

Social Sciences